Investment
Features
FeesSafety
Academy
More
Pluang+

Morgan Stanley Direct Lending Fund faces worsening results, likely dividend cut ahead.

Company Fundamentals
13 Aug 2026
Seeking Alpha
View Source
Bearish
pluang ai news

Morgan Stanley Direct Lending Fund (MSDL) reported weaker Q2 2026 results with declining dividend coverage, a drop in net asset value (NAV), and doubled non-accrual loans. These issues suggest the fund may need to reduce its dividend payout again. The analyst downgraded MSDL to a hold last month due to these deteriorating fundamentals and a previous valuation increase. A further dividend cut could lead to a valuation pullback, which might present a buying opportunity later.

More News

TOMI Environmental posts 118% revenue growth and beats EPS estimates despite ongoing losses

TOMI Environmental posts 118% revenue growth and beats EPS estimates despite ongoing losses

TOMI Environmental Solutions reported a 118% year-over-year revenue increase to $2.25 million, surpassing analyst estimates of $1.84 million. The company also beat EPS expectations with a loss of $0.05 per share, better than the anticipated loss of $...

Company Fundamentals
Bullish
12 minutes ago
Madison Square Garden Sports price target raised on strong Q4 results and Knicks' NBA win

Madison Square Garden Sports price target raised on strong Q4 results and Knicks' NBA win

Seaport Global raised the price target for Madison Square Garden Sports Corp. to $473, reflecting a 17.13% potential upside. The company reported strong fiscal Q4 results with earnings per share of $1.19, beating estimates of $0.72, and revenue risin...

Company Fundamentals
Bullish
1 hour ago
Airbus leads aerospace market with strong orders despite production challenges

Airbus leads aerospace market with strong orders despite production challenges

Airbus is outperforming Boeing in commercial aircraft orders, securing 821 net orders in H1 2026 compared to Boeing's 408. Morgan Stanley maintains an "Overweight" rating on Airbus, raising its price target to €255, reflecting confidence in the compa...

Market News
Bullish
1 hour ago
PAVmed reports Q2 loss narrower than expected, revenue below estimates, plans FDA submission in 2027

PAVmed reports Q2 loss narrower than expected, revenue below estimates, plans FDA submission in 2027

PAVmed reported a Q2 2026 GAAP loss per share of $0.87 and a non-GAAP loss of $0.27, beating analyst expectations of a $0.47 loss. Revenue was $33,000, below the $49,000 consensus. Lucid Diagnostics, an investment of PAVmed, generated $1.5 million in...

Company Fundamentals
Bearish
1 hour ago
Target's stock may face a pullback despite strong Q2 earnings forecast and 57% YTD surge.

Target's stock may face a pullback despite strong Q2 earnings forecast and 57% YTD surge.

Target is expected to report second-quarter earnings of $2.25 per share, a 9.8% increase from last year, with revenues projected at $26.06 billion, up 3.4%. Despite these positive forecasts, the stock has surged 57% year-to-date, leading an analyst t...

Company Fundamentals
Neutral
2 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App